LN:RB Reckitt Benckiser Group plc

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl, and Strepsils brand names. It also offers hygienic products, including surface care and lavatory care products, antiseptic liquids, pest control products, automatic dishwashing products, and depilatory products under the Cillit Bang, Clearasil, Dettol, Finish, Harpic, Lysol, Mortein, and Veet brand names. In addition, the company offers home products, such as fabric treatment products, water softeners, and air care products under the Vanish, Calgon, and Air Wick brand names, as well as food products under the French's brand name. Further, it provides infant formula, children's nutrition, and other nutritional products. The company operates in Europe, Russia, the CIS, Israel, North America, Australia, New Zealand, North Africa, the Middle East, Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea, and ASEAN countries. Reckitt Benckiser Group plc was founded in 1823 and is headquartered in Slough, the United Kingdom.This company has ADRs that trade in the U.S. as the symbol RBGLY.

6,498.00 GBP
As of 03/31/2021

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Consumer Staples
Industry:  
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  01/04/2000
Stock exchange:    London Stock Exchange
Exchange country:   United Kingdom
Market cap:   0 GBP
Current dividend yield:   2.73%
Sedol:      B24CGK7